ResearcherUniversity Hospital MünsterActive in the last 2 years
Anda Ströse
Matched on ORCID iD 0000-0002-7177-4105; OpenAlex author ID A5067280647. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 5
- Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. Co-author DOI 10.3390/cancers16162825↗
- Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers12061693↗
- Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma. Co-author DOI 10.1007/s00432-018-2749-7↗
- Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers10090328↗
- MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1371/journal.pone.0143755↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sameer Abdallah Dhayat · 5 shared papers, 2015–2024 · strength 0.63
- Paper Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Canc… DOI 10.3390/cancers16162825↗
- Paper Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers12061693↗
- Paper Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma. DOI 10.1007/s00432-018-2749-7↗
- Isabelle Flammang · 2 shared papers, 2020–2024 · strength 0.39
- Moritz Reese · 2 shared papers, 2020–2024 · strength 0.39
- Zixuan Yang · 2 shared papers, 2020–2024 · strength 0.39
- Norbert J. Senninger · 3 shared papers, 2015–2018 · strength 0.23
- Paper Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma. DOI 10.1007/s00432-018-2749-7↗
- Paper Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers10090328↗
- Paper MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma. DOI 10.1371/journal.pone.0143755↗
- Konrad Steinestel · 1 shared paper, 2018 · strength 0.09
- Max M. Träger · 1 shared paper, 2018 · strength 0.09
- Wolf Arif Mardin · 1 shared paper, 2015 · strength 0.05
- Jörg Haier · 1 shared paper, 2015 · strength 0.05
- Soeren Torge Mees · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.